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Background
Spontaneous control of HIV to <50 copies RNA/ml is
observed in rare individuals. An improved understanding
of this phenomenon may provide insight into host mech-
anisms that can be modulated for therapeutic benefit by
vaccines. Recent studies of these 'elite' controllers (EC)
revealed HLA-associated changes in Gag-Protease that
resulted in reduced replication capacity. This project
assessed the possibility of immune-mediated defects in
the Pol gene (RT-Integrase) of EC.
Methods
Chimeric NL4-3 mutants encoding patient plasma-
derived RT-Integrase sequences from EC (N = 58) and
chronic progressors (N = 50) were constructed by homol-
ogous recombination. Replication capacity (RC) for each
variant strain was assessed using a GFP-reporter T cell
assay. Results were correlated with clinical and host
genetic factors, including CD4 count, plasma viral load
(pVL), and patient HLA.
Results
Viruses encoding Pol sequences from EC replicated signif-
icantly less well than those from individuals with progres-
sive disease (Mann-Whitney, p < 0.0001). No association
was observed between RC and CD4 T cell count in EC or
progressors, nor between RC and pVL in progressors
(Spearman, all p > 0.05). Viruses derived from HLA-B57+
EC (N = 20) appeared to replicate slower than those from
B57+ progressors (N = 8) (p = 0.004). Similar results were
observed between B51+ EC (N = 4) and B51+ progressors
(N = 10) (p = 0.024), but not between B27+ EC (N = 9)
and B27+ progressors (N = 5) (p = 0.437).
Conclusion
This study extends previous observations for Gag and
demonstrates that Pol variants from EC also display
reduced function. The association between fitness and
expression of certain HLA that present Pol epitopes sug-
gests that immune-mediated mutations impairing viral
fitness may play a key role in spontaneous control of HIV.
Results indicate that HLA alleles responsible for such
defects in protein function may differ among viral genes.
Further identification of HLA-associated changes in HIV
may allow design of vaccines targeting the most vulnera-
ble regions of the virus.
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